The team at Linklaters LLP has broad expertise spanning trade mark infringement disputes, joint R&D agreements, and supply and logistics arrangements, often assisting financial sponsors, insurers and medical device companies. The group is also noted for its expertise in data protection, regulatory investigation, and product liability matters. Aisling Zarraga co-heads the practice, and has a great deal of expertise in handling both public and private M&A issues and joint ventures for international pharmaceutical companies, healthcare service providers and biotech corporates. Co-head Marly Didizian has broad knowledge surrounding carve outs, pharmaceutical supply chains, and advance purchase agreements involving vaccine manufacturers. Since publication, Katie Coltart has joined from Kirkland & Ellis International LLP.
Key clients
- Gavi
- Apax Partners
- The Carlyle Group
- Fresenius
- PAI Partners
- Hg Capital
- Bayer
- Nestlé
- Takeda Pharmaceuticals
- McKesson Corporation
- Merck & Co., Inc.
- Sanofi
- Regeneron Pharmaceuticals
- ViiV
- Thermo Fisher Scientific Inc
Work highlights
- Advised ThermoFisher on its acquisition of The Binding Site Group, and related IP issues.
- Represented ViiV Healthcare (a joint venture involving GSK) in UK patent infringement proceedings against Gilead in relation to Gilead's HIV treatment bictegravir.
- Advised Gavi on purchase agreements for Covid-19 vaccines with vaccine manufacturers.
Lawyers
Practice head
The lawyer(s) leading their teams.
Aisling Zarraga, Marly Didizian